Research Age-Related Macular Degeneration (AMD) Grant
Researchers in the Department of Ophthalmology at the University of Colorado School of Medicine have received nearly $4 million in R01 grants from the National Institutes of Health (NIH) to move forward in their work at CellSight, the Ocular Stem Cell and Regeneration Research Program based at the Sue Anschutz-Rodgers Eye Center.
Research Age-Related Macular Degeneration (AMD)
There is little to no difference in terms of effectiveness and safety between anti-vascular endothelial growth factor (anti-VEGF) medications and biosimilars used to treat neovascular age-related macular degeneration (nAMD), researchers from the Department of Ophthalmology at the University of Colorado School of Medicine say in a new Cochrane Eyes and Vision systematic review.
Research Age-Related Macular Degeneration (AMD)
When Anne Lynch, MD, MSPH, professor and director of the Division of Ophthalmic Epidemiology in the University of Colorado Department of Ophthalmology, wanted to recruit more patients with early and intermediate age-related macular degeneration for research, she and a team of researchers turned to social media to engage the community.
Research Mental Health Low Vision Rehabilitation Age-Related Macular Degeneration (AMD)
Researchers in the Division of Ophthalmic Epidemiology in the University of Colorado Department of Ophthalmology have confirmed an association between vision loss from advanced age-related macular degeneration (AMD) with depression, following a study of patient data collected over seven years. This finding will help bring visibility into the impact of the disease, which is a leading cause of vision loss for older adults.
Research Age-Related Macular Degeneration (AMD) Retina
Generating retinas from stem cells and transplant technologies to restore human sight felt like just a dream for Valeria Canto-Soler, PhD, associate professor of ophthalmology in the University of Colorado School of Medicine. When she joined the CU Department of Ophthalmology faculty in 2017, she signed on as the inaugural director of CellSight, the department’s ocular stem cell and regeneration research program, setting benchmarks 15 years in the future.
HCP Live
July 26, 2024
Maternal asthma could increase the likelihood of a blinding eye disease in premature infants, according to a new study by investigator led by Zafar Gill, MD, a vitreoretinal diseases and surgery fellow in the Department of Ophthalmology.
Ophthalmology Times
July 22, 2024
Riaz Qureshi, PhD, an assistant professor of ophthalmology at the University of Colorado School of Medicine, recently published a paper in Annals of Internal Medicine that features an international team of researchers that has established a framework providing guidance to authors, peer reviewers, and editors to rectify spin of harms in systematic review.
Cosmos Magazine
July 22, 2024
An international group of medical researchers led by Riaz Qureshi, PhD, assistant professor of ophthalmology, is calling for a better understanding of “spin” in research papers.
CPR
July 19, 2024
“I think their position is ridiculous and negligent,” said Dr. Michael Puente, a pediatric ophthalmologist at the University of Colorado and Children’s Hospital Colorado in Aurora. “It’s ridiculous that a policy still exists with no scientific evidence to support it.”
Kara Mason
